Jennotte, Olivier ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Koch, Nathan ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Lechanteur, Anna ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Language :
English
Title :
Formulation and quality consideration of cannabidiol printed forms produced by fused-deposition modeling
Ryan, M., Cannabidiol in epilepsy: the indications and beyond. Ment. Heal. Clin. 10 (2020), 317–325, 10.9740/mhc.2020.11.317.
Mazurkiewicz-Bełdzińska, M., Zawadzka, M., Use of cannabidiol in the treatment of epilepsy. Neurol. Neurochir. Pol. 56 (2022), 14–20, 10.5603/PJNNS.a2022.0020.
Bergamaschi, M.M., Helena Costa Queiroz, R., Hortes, M., Chagas, N., Chaves Gomes De Oliveira, D., De Martinis, B.S., Kapczinski, F., Quevedo, J., Roesler, R., Schrö Der, N., Nardi, A.E., Martín-Santos, R., Hallak, J.E.C., Zuardi, A.W., Alexandre, J., Crippa, S., Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients. Neuropsychopharmacology 36 (2011), 1219–1226, 10.1038/npp.2011.6.
Heider, C.G., Itenberg, S.A., Rao, J., Ma, H., Wu, X., Mechanisms of cannabidiol (CBD) in cancer treatment: a review. https://doi.org/10.3390/biology11060817, 2022.
McGuire, P., Robson, P., Cubala, W.J., Vasile, D., Morrison, P.D., Barron, R., Taylor, A., Wright, S., Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial. Am. J. Psychiatr. 175 (2018), 225–231, 10.1176/appi.ajp.2017.17030325.
Hurd, Y.L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., Oprescu, A.M., Salsitz, E., Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial. Am. J. Psychiatr. 176 (2019), 911–922, 10.1176/appi.ajp.2019.18101191.
Millar, S., Stone, N., Bellman, Z., Yates, A., England, T., Sophie Millar, C.A., A systematic review of cannabidiol dosing in clinical populations. Artelo Biosci. Biotechnol. Biol. Sci. Res. Counc., 2019, 10.1111/bcp.14038.
Feeney, O.M., Crum, M.F., McEvoy, C.L., Trevaskis, N.L., Williams, H.D., Pouton, C.W., Charman, W.N., Bergström, C.A.S., Porter, C.J.H., 50 years of oral lipid-based formulations: provenance, progress and future perspectives. Adv. Drug Deliv. Rev. 101 (2016), 167–194, 10.1016/j.addr.2016.04.007.
Nakano, Y., Tajima, M., Sugiyama, E., Sato, V.H., Sato, H., Development of a novel nano-emulsion formulation to improve intestinal absorption of cannabidiol. Med. Cannabis Cannabinoids 2 (2019), 35–42, 10.1159/000497361.
Williams, N.N.B., Ewell, T.R., Abbotts, K.S.S., Harms, K.J., Woelfel, K.A., Dooley, G.P., Weir, T.L., Bell, C., Comparison of five oral cannabidiol preparations in adult humans: pharmacokinetics, body composition, and heart rate variability. Pharmaceuticals 14 (2021), 1–14, 10.3390/ph14010035.
Hobbs, J.M., Vazquez, A.R., Remijan, N.D., Trotter, R.E., V McMillan, T., Freedman, K.E., Wei, Y., Woelfel, K.A., Arnold, O.R., Wolfe, L.M., Johnson, S.A., Weir, T.L., Sarah Johnson, C.A., Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults. https://doi.org/10.1002/ptr.6651, 2020.
Tran, B.N., Van Pham, Q., Tran, B.T., Thien Le, G., Dao, A.H., Tran, T.H., Nguyen, C.N., Supercritical CO2 impregnation approach for enhancing dissolution of fenofibrate by adsorption onto high-surface area carriers. J. Supercrit. Fluids, 184, 2022, 105584, 10.1016/j.supflu.2022.105584.
Petitprez, J., Legrand, François-Xavier, Catherine Tams, Pipkin, J.D., Antle, V., Kfoury, M., Fourmentin, S., Huge solubility increase of poorly water-soluble pharmaceuticals by sulfobutylether-β-cyclodextrin complexation in a low-melting mixture. Environ. Chem. Lett. 20 (2022), 1561–1568, 10.1007/s10311-022-01415-y.
Singh, A., Van den Mooter, G., Spray drying formulation of amorphous solid dispersions. Adv. Drug Deliv. Rev. 100 (2016), 27–50, 10.1016/j.addr.2015.12.010.
Jennotte, O., Koch, N., Lechanteur, A., Evrard, B., Development of amorphous solid dispersions of cannabidiol: influence of the carrier, the hot-melt extrusion parameters and the use of a crystallization inhibitor. J. Drug Deliv. Sci. Technol., 71, 2022, 103372, 10.1016/j.jddst.2022.103372.
Koutsamanis, I., Spoerk, M., Arbeiter, F., Eder, S., Roblegg, E., Development of porous polyurethane implants manufactured via hot-melt extrusion. Polymers (Basel), 12, 2020, 10.3390/polym12122950.
Butreddy, A., Sarabu, S., Bandari, S., Batra, A., Lawal, K., Chen, N.N., Bi, V., Durig, T., Repka, M.A., Influence of plasdone TM S630 ultra-an improved copovidone on the processability and oxidative degradation of quetiapine fumarate amorphous solid dispersions prepared via hot-melt extrusion technique. AAPS PharmSciTech, 22, 2021, 196, 10.1208/s12249-021-02069-9.
Mohammed, N.N., Majumdar, S., Singh, A., Deng, W., Murthy, N.S., Pinto, E., Tewari, D., Durig, T., Repka, M.A., KlucelTM EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology. AAPS PharmSciTech 13 (2012), 1158–1169, 10.1208/s12249-012-9834-z.
Dumpa, N., Butreddy, A., Wang, H., Komanduri, N., Bandari, S., Repka, M.A., 3D printing in personalized drug delivery: an overview of hot-melt extrusion-based fused deposition modeling. Int. J. Pharm., 600, 2021, 120501, 10.1016/j.ijpharm.2021.120501.
Samiei, N., Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: a mini review. Beni-Suef Univ. J. Basic Appl. Sci., 9, 2020, 10.1186/s43088-020-00040-4.
Quodbach, J., Bogdahn, M., Breitkreutz, J., Chamberlain, R., Eggenreich, K., Elia, A.G., Gottschalk, N., Gunkel-Grabole, G., Hoffmann, L., Kapote, D., Kipping, T., Klinken, S., Loose, F., Marquetant, T., Windolf, H., Geißler, S., Spitz, T., Quality of FDM 3D printed medicines for pediatrics: considerations for formulation development, filament extrusion, printing process and printer design. Ther. Innov. Regul. Sci. 56 (2022), 910–928, 10.1007/s43441-021-00354-0.
Goyanes, A., Fina, F., Martorana, A., Sedough, D., Gaisford, S., Basit, A.W., Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int. J. Pharm. 527 (2017), 21–30, 10.1016/j.ijpharm.2017.05.021.
Sadia, M., Isreb, A., Abbadi, I., Isreb, M., Aziz, D., Selo, A., Timmins, P., Alhnan, M.A., From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. Eur. J. Pharmaceut. Sci. 123 (2018), 484–494, 10.1016/j.ejps.2018.07.045.
Scoutaris, N., Ross, S.A., Douroumis, D., 3D Printed B Starmix ^ Drug Loaded Dosage Forms for Paediatric Applications. 2018, 1–11.
Maroni, A., Melocchi, A., Parietti, F., Foppoli, A., Zema, L., Gazzaniga, A., 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J. Contr. Release 268 (2017), 10–18, 10.1016/j.jconrel.2017.10.008.
Mohapatra, S., Kar, R.K., Biswal, P.K., Bindhani, S., Approaches of 3D printing in current drug delivery. Sensors Int, 3, 2022, 100146, 10.1016/j.sintl.2021.100146.
Norman, J., Madurawe, R.D., Moore, C.M.V., Khan, M.A., Khairuzzaman, A., A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv. Drug Deliv. Rev. 108 (2017), 39–50, 10.1016/j.addr.2016.03.001.
Izgelov, D., Freidman, M., Hoffman, A., Investigation of cannabidiol gastro retentive tablets based on regional absorption of cannabinoids in rats. Eur. J. Pharm. Biopharm. 152 (2020), 229–235, 10.1016/j.ejpb.2020.05.010.
Koch, N., Jennotte, O., Gasparrini, Y., Vandenbroucke, F., Lechanteur, A., Evrard, B., Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers. Int. J. Pharm., 589, 2020, 119812, 10.1016/j.ijpharm.2020.119812.
Pitt, K.G., Heasley, M.G., Determination of the tensile strength of elongated tablets. Powder Technol. 238 (2013), 169–175, 10.1016/j.powtec.2011.12.060.
Aho, J., Bøtker, J.P., Genina, N., Edinger, M., Arnfast, L., Roadmap to 3D-printed oral pharmaceutical dosage forms : feedstock filament properties and characterization for fused deposition modeling. J. Pharmaceut. Sci. 108 (2019), 26–35, 10.1016/j.xphs.2018.11.012.
Parulski, C., Jennotte, O., Lechanteur, A., Evrard, B., Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now?. Adv. Drug Deliv. Rev., 175, 2021, 10.1016/j.addr.2021.05.020.
Gültekin, H.E., Tort, S., Acartürk, F., Fabrication of three dimensional printed tablets in flexible doses: a comprehensive study from design to evaluation. SSRN Electron. J., 74, 2022, 103538, 10.2139/ssrn.4028237.
Sadia, M., So, A., Arafat, B., Isreb, A., Ahmed, W., Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int. J. Pharm. 513 (2016), 659–668, 10.1016/j.ijpharm.2016.09.050.
Henry, S., De Wever, L., Vanhoorne, V., De Beer, T., Vervaet, C., Influence of print settings on the critical quality attributes of extrusion-based 3d-printed caplets: a quality-by-design approach. Pharmaceutics, 13, 2021, 10.3390/PHARMACEUTICS13122068.
Crowley, M.M., Zhang, F., Repka, M.A., Thumma, S., Upadhye, S.B., Battu, S.K., McGinity, J.W., Martin, C., Pharmaceutical applications of hot-melt extrusion: Part I. Drug Dev. Ind. Pharm. 33 (2007), 909–926, 10.1080/03639040701498759.
Macedo, J., Samaro, A., Vanhoorne, V., Vervaet, C., Pinto, J.F., Processability of poly(vinyl alcohol) based filaments with paracetamol prepared by hot-melt extrusion for additive manufacturing. J. Pharmaceut. Sci. 109 (2020), 3636–3644, 10.1016/j.xphs.2020.09.016.
Lin, X., Su, L., Li, N., Hu, Y., Tang, G., Liu, L., Li, H., Yang, Z., Understanding the mechanism of dissolution enhancement for poorly water-soluble drugs by solid dispersions containing Eudragit® E PO. J. Drug Deliv. Sci. Technol. 48 (2018), 328–337, 10.1016/j.jddst.2018.10.008.
Lin, X., Su, L., Li, N., Hu, Y., Tang, G., Liu, L., Li, H., Yang, Z., Understanding the mechanism of dissolution enhancement for poorly water- soluble drugs by solid dispersions containing Eudragit ® E PO. J. Drug Deliv. Sci. Technol. 48 (2018), 328–337, 10.1016/j.jddst.2018.10.008.
Shojaee, S., Emami, P., Mahmood, A., Rowaiye, Y., Dukulay, A., Kaialy, W., Cumming, I., Nokhodchi, A., An investigation on the effect of polyethylene oxide concentration and particle size in modulating theophylline release from tablet matrices. AAPS PharmSciTech 16 (2015), 1281–1289, 10.1208/s12249-015-0295-z.
Tamir, T.S., Xiong, G., Fang, Q., Dong, X., Shen, Z., Wang, F.Y., A feedback-based print quality improving strategy for FDM 3D printing: an optimal design approach. Int. J. Adv. Manuf. Technol. 120 (2022), 2777–2791, 10.1007/s00170-021-08332-4.
Obeid, S., Madžarević, M., Krkobabić, M., Ibrić, S., Predicting drug release from diazepam FDM printed tablets using deep learning approach: influence of process parameters and tablet surface/volume ratio. Int. J. Pharm., 601, 2021, 10.1016/j.ijpharm.2021.120507.
Wei, C., Solanki, N.G., Vasoya, J.M., Shah, A.V., Serajuddin, A.T.M., Development of 3D printed tablets by fused deposition modeling using polyvinyl alcohol as polymeric matrix for rapid drug release. J. Pharmaceut. Sci. 109 (2020), 1558–1572, 10.1016/j.xphs.2020.01.015.
Parulski, C., Gresse, E., Jennotte, O., Felten, A., Ziemons, E., Lechanteur, A., Evrard, B., Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: how to elucidate drug dissolution mechanisms through surface spectral analysis techniques?. Int. J. Pharm., 626, 2022, 10.1016/j.ijpharm.2022.122157.
Skowyra, J., Pietrzak, K., Alhnan, M.A., Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur. J. Pharmaceut. Sci. 68 (2015), 11–17, 10.1016/j.ejps.2014.11.009.
Nukala, P.K., Palekar, S., Solanki, N., Fu, Y., Patki, M., Shohatee, A.A., Trombetta, L., Patel, K., Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms. J. 3D Print. Med. 3 (2019), 23–37, 10.2217/3dp-2018-0028.
Fanous, M., Bitar, M., Gold, S., Sobczuk, A., Hirsch, S., Ogorka, J., Imanidis, G., Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: study of morphology, solid state and dissolution. Int. J. Pharm., 599, 2021, 120417, 10.1016/j.ijpharm.2021.120417.
Goyanes, A., Robles Martinez, P., Buanz, A., Basit, A.W., Gaisford, S., Effect of geometry on drug release from 3D printed tablets. Int. J. Pharm. 494 (2015), 657–663, 10.1016/j.ijpharm.2015.04.069.
Kempin, W., Domsta, V., Grathoff, G., Brecht, I., Semmling, B., Tillmann, S., Weitschies, W., Seidlitz, A., Immediate Release 3D-Printed Tablets Produced via Fused Deposition Modeling of a Thermo-Sensitive Drug. 2018.
Alhijjaj, M., Belton, P., Qi, S., An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing. Eur. J. Pharm. Biopharm. 108 (2016), 111–125, 10.1016/j.ejpb.2016.08.016.
Crișan, A.G., Iurian, S., Porfire, A., Rus, L.M., Bogdan, C., Casian, T., Lucacel, R.C., Turza, A., Porav, S., Tomuță, I., QbD guided development of immediate release FDM-3D printed tablets with customizable API doses. Int. J. Pharm., 613, 2022, 10.1016/j.ijpharm.2021.121411.
Kibria, G., Roni, M.A., Absar, M.S., Jalil, R.U., Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with eudragit RS 30 D. AAPS PharmSciTech 9 (2008), 1240–1246, 10.1208/s12249-008-9163-4.
Liu, H., Wang, P., Zhang, X., Shen, F., Gogos, C.G., Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit ® E PO solid dispersions. Int. J. Pharm. 383 (2010), 161–169, 10.1016/j.ijpharm.2009.09.003.
